BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 17369846)

  • 1. CUTL1 promotes tumor cell migration by decreasing proteasome-mediated Src degradation.
    Aleksic T; Bechtel M; Krndija D; von Wichert G; Knobel B; Giehl K; Gress TM; Michl P
    Oncogene; 2007 Aug; 26(40):5939-49. PubMed ID: 17369846
    [TBL] [Abstract][Full Text] [Related]  

  • 2. WNT5A--target of CUTL1 and potent modulator of tumor cell migration and invasion in pancreatic cancer.
    Ripka S; König A; Buchholz M; Wagner M; Sipos B; Klöppel G; Downward J; Gress T; Michl P
    Carcinogenesis; 2007 Jun; 28(6):1178-87. PubMed ID: 17227781
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Csk-binding protein (Cbp) negatively regulates epidermal growth factor-induced cell transformation by controlling Src activation.
    Jiang LQ; Feng X; Zhou W; Knyazev PG; Ullrich A; Chen Z
    Oncogene; 2006 Sep; 25(40):5495-506. PubMed ID: 16636672
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CUTL1 is a target of TGF(beta) signaling that enhances cancer cell motility and invasiveness.
    Michl P; Ramjaun AR; Pardo OE; Warne PH; Wagner M; Poulsom R; D'Arrigo C; Ryder K; Menke A; Gress T; Downward J
    Cancer Cell; 2005 Jun; 7(6):521-32. PubMed ID: 15950902
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RAFTK/Pyk2 tyrosine kinase mediates the association of p190 RhoGAP with RasGAP and is involved in breast cancer cell invasion.
    Zrihan-Licht S; Fu Y; Settleman J; Schinkmann K; Shaw L; Keydar I; Avraham S; Avraham H
    Oncogene; 2000 Mar; 19(10):1318-28. PubMed ID: 10713673
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CUTL1: a key mediator of TGFbeta-induced tumor invasion.
    Michl P; Downward J
    Cell Cycle; 2006 Jan; 5(2):132-4. PubMed ID: 16357536
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Negative regulation of protease-activated receptor 1-induced Src kinase activity by the association of phosphocaveolin-1 with Csk.
    Lu TL; Kuo FT; Lu TJ; Hsu CY; Fu HW
    Cell Signal; 2006 Nov; 18(11):1977-87. PubMed ID: 16678999
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MUC1 initiates Src-CrkL-Rac1/Cdc42-mediated actin cytoskeletal protrusive motility after ligating intercellular adhesion molecule-1.
    Shen Q; Rahn JJ; Zhang J; Gunasekera N; Sun X; Shaw AR; Hendzel MJ; Hoffman P; Bernier A; Hugh JC
    Mol Cancer Res; 2008 Apr; 6(4):555-67. PubMed ID: 18403635
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes in androgen receptor nongenotropic signaling correlate with transition of LNCaP cells to androgen independence.
    Unni E; Sun S; Nan B; McPhaul MJ; Cheskis B; Mancini MA; Marcelli M
    Cancer Res; 2004 Oct; 64(19):7156-68. PubMed ID: 15466214
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phosphorylated caveolin-1 regulates Rho/ROCK-dependent focal adhesion dynamics and tumor cell migration and invasion.
    Joshi B; Strugnell SS; Goetz JG; Kojic LD; Cox ME; Griffith OL; Chan SK; Jones SJ; Leung SP; Masoudi H; Leung S; Wiseman SM; Nabi IR
    Cancer Res; 2008 Oct; 68(20):8210-20. PubMed ID: 18922892
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CdGAP is required for transforming growth factor β- and Neu/ErbB-2-induced breast cancer cell motility and invasion.
    He Y; Northey JJ; Primeau M; Machado RD; Trembath R; Siegel PM; Lamarche-Vane N
    Oncogene; 2011 Mar; 30(9):1032-45. PubMed ID: 21042277
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RaLP, a new member of the Src homology and collagen family, regulates cell migration and tumor growth of metastatic melanomas.
    Fagiani E; Giardina G; Luzi L; Cesaroni M; Quarto M; Capra M; Germano G; Bono M; Capillo M; Pelicci P; Lanfrancone L
    Cancer Res; 2007 Apr; 67(7):3064-73. PubMed ID: 17409413
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Essential roles of Lyn in fibronectin-mediated filamentous actin assembly and cell motility in mast cells.
    Suzuki T; Shoji S; Yamamoto K; Nada S; Okada M; Yamamoto T; Honda Z
    J Immunol; 1998 Oct; 161(7):3694-701. PubMed ID: 9759894
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of c-Src/HER1/STAT5b and HER1/ERK1/2 signaling pathways and cell migration by hexachlorobenzene in MDA-MB-231 human breast cancer cell line.
    Pontillo CA; García MA; Peña D; Cocca C; Chiappini F; Alvarez L; Kleiman de Pisarev D; Randi AS
    Toxicol Sci; 2011 Apr; 120(2):284-96. PubMed ID: 21205633
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fibronectin and type IV collagen activate ERalpha AF-1 by c-Src pathway: effect on breast cancer cell motility.
    Sisci D; Aquila S; Middea E; Gentile M; Maggiolini M; Mastroianni F; Montanaro D; Andò S
    Oncogene; 2004 Nov; 23(55):8920-30. PubMed ID: 15467744
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transmembrane phosphoprotein Cbp senses cell adhesion signaling mediated by Src family kinase in lipid rafts.
    Shima T; Nada S; Okada M
    Proc Natl Acad Sci U S A; 2003 Dec; 100(25):14897-902. PubMed ID: 14645715
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TGF-beta1 (transforming growth factor-beta1)-mediated adhesion of gastric carcinoma cells involves a decrease in Ras/ERKs (extracellular-signal-regulated kinases) cascade activity dependent on c-Src activity.
    Kim HP; Lee MS; Yu J; Park JA; Jong HS; Kim TY; Lee JW; Bang YJ
    Biochem J; 2004 Apr; 379(Pt 1):141-50. PubMed ID: 14720123
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of miRNA expression by Src and contact normalization: effects on nonanchored cell growth and migration.
    Li X; Shen Y; Ichikawa H; Antes T; Goldberg GS
    Oncogene; 2009 Dec; 28(48):4272-83. PubMed ID: 19767772
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cutl1: a potential target for cancer therapy.
    Liu KC; Lin BS; Zhao M; Wang KY; Lan XP
    Cell Signal; 2013 Jan; 25(1):349-54. PubMed ID: 23085261
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SRC uses Cas to suppress Fhl1 in order to promote nonanchored growth and migration of tumor cells.
    Shen Y; Jia Z; Nagele RG; Ichikawa H; Goldberg GS
    Cancer Res; 2006 Feb; 66(3):1543-52. PubMed ID: 16452211
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.